Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 241.55
+1.65 (0.69%)
Oct 29, 2025, 3:30 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 29.63 billion as of October 29, 2025. Its market cap has decreased by -29.26% in one year.
Market Cap
29.63B
Enterprise Value
37.10B
Revenue
18.33B
Ranking
n/a
PE Ratio
46.81
Stock Price
241.55
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 29.63B, an increase of 2,083.10%. That is a compound annual growth rate of 14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 29.78B | -38.06% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | 20.31B | 44.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.27T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.01T |
| Mankind Pharma | 993.30B |
| Fortis Healthcare | 797.99B |
| Alkem Laboratories | 649.48B |